Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Reid

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Nature Communications|May 6, 2020
Genomic landscape of platinum resistant and sensitive testicular cancersChey Loveday, Kevin Litchfield, Paula Z Proszek, et al.
Cancer Medicine|November 13, 2019
Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)Ben Tran, Jose M Ruiz-Morales, Enrique Gonzalez-Billalabeitia, et al.
Nature Cancer|July 12, 2024
Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancerJavier Fernandez-Mateos, George D Cresswell, Nicholas Trahearn, et al.
European Urology Focus|October 9, 2020
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line ChemotherapyChristian Daniel Fankhauser, Ben Tran, Manuel Pedregal, et al.
BJC Reports|November 8, 2024
Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genesSarah Benafif, Ann-Britt Jones, Susan Merson, et al.
Nature Genetics|June 13, 2017
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumorKevin Litchfield, Max Levy, Giulia Orlando, et al.
Medicinal Research Reviews|December 14, 2004
Preparation of kinase-biased compounds in the search for lead inhibitors of kinase targetsJustine Y Q Lai, Steven Langston, Ruth Adams, et al.
Andrology|May 25, 2026
Improving the Understanding of Late Effects of Testicular Cancer in Adolescent and Young Adult Survivors: TRANSCEND-XRMohamad M Saab, Josephine Hegarty, Jack P Gleeson, et al.
Nature Cancer|February 5, 2022
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Research Square|September 28, 2021
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Nature Communications|May 6, 2020
Genomic landscape of platinum resistant and sensitive testicular cancersChey Loveday, Kevin Litchfield, Paula Z Proszek, et al.
Cancer Medicine|November 13, 2019
Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)Ben Tran, Jose M Ruiz-Morales, Enrique Gonzalez-Billalabeitia, et al.
Nature Cancer|July 12, 2024
Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancerJavier Fernandez-Mateos, George D Cresswell, Nicholas Trahearn, et al.
European Urology Focus|October 9, 2020
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line ChemotherapyChristian Daniel Fankhauser, Ben Tran, Manuel Pedregal, et al.
BJC Reports|November 8, 2024
Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genesSarah Benafif, Ann-Britt Jones, Susan Merson, et al.
Nature Genetics|June 13, 2017
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumorKevin Litchfield, Max Levy, Giulia Orlando, et al.
Medicinal Research Reviews|December 14, 2004
Preparation of kinase-biased compounds in the search for lead inhibitors of kinase targetsJustine Y Q Lai, Steven Langston, Ruth Adams, et al.
Andrology|May 25, 2026
Improving the Understanding of Late Effects of Testicular Cancer in Adolescent and Young Adult Survivors: TRANSCEND-XRMohamad M Saab, Josephine Hegarty, Jack P Gleeson, et al.
Nature Cancer|February 5, 2022
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Research Square|September 28, 2021
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Pageof 17